95
Participants
Start Date
August 29, 2017
Primary Completion Date
July 16, 2018
Study Completion Date
July 16, 2018
CX-8998
T-type calcium channel blocker
Placebo
Placebo comparator
Columbia University, New York
Wake Research Associates, LLC, Raleigh
Emory University School of Medicine, Atlanta
Meridian Neurology Clinical Research, Savannah
Parkinson's Disease and Movement Disorders Center of Boca Raton, Boca Raton
University of South Florida, Tampa
Vanderbilt University, Nashville
Midwest Clinical Research Center, Dayton
University of Michigan, Ann Arbor
Henry Ford Hospital West Bloomfield, West Bloomfield
Quest Research Institute, Farmington Hills
Northwestern Medical Group, Chicago
Washington University School of Medicine, St Louis
St. Louis Clinical Trials, St Louis
University of Kansas Medical Center, Kansas City
Woodland International Research Group, Little Rock
Woodland Research Northwest, Rogers
Houston Methodist Neurological Institute, Houston
Tucson Neuroscience Research, Tucson
University of California San Diego, La Jolla
Pacific Research Network, San Diego
Boston University Medical Center, Boston
Lead Sponsor
Jazz Pharmaceuticals
INDUSTRY